How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AK

NASDAQ:AKYA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AK

Akoya Biosciences IncNASDAQ AKYA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is AKYA undervalued compared to its fair value?

The fair value of AKYA stock is hidden USD. Relative to the market price of 2.47 USD Akoya Biosciences Inc is hidden.

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and c...[More about valuation]

Akoya Biosciences Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.117 $B

Price:

2.47 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.477

FINANCIALS

Akoya Biosciences financial for reporting period

Income Statement

0.018 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.017 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.023 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.018 B 100%
0.0084 B 46%
-0.017 B -94%
-0.023 B -128%

Balance Sheet

0.15 B
0.033 B

0.077 B

Financial Position Analysis

Assets

0.15 B
Current Assets
0.1 B
Total non-current assets
0.053 B

Total current liabilities
0.033 B
Total non-current liabilities
0.089 B

Cash Flow Statement

-0.022 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.021 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Akoya Biosciences fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-123 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-88 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-39 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Akoya Rating

Is AKYA attractive for investment based on fundamental analysis?

AKYA stock rating is hidden. Akoya Biosciences is a hidden by Eyestock methodology.

Get AKYA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-73

Gross Margin:

56

CFO / Debt ratio:

hidden

Current ratio:

3.3

Debt / Equity ratio:

1.291

ROE:

-123

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

AKYA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for AKYA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Akoya Biosciences Inc dividends

AKYA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About AKYA stock

About the company Akoya Biosciences Inc

Market cap $B

0.117

Dividend yield

Shares outstanding

38.3419 B

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 369 full-time employees. The company went IPO on 2021-04-16. The firm delivers spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. The company provides PhenoImager HT, which is a digital pathology imager featuring rapid whole-slide multispectral scanning of up to seven colors with an 80-slide capacity. The company offers a contract research services laboratory, which is called Advanced Biopharma Solutions (ABS).

AKYA profile

  • Ticker

    AKYA

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    16 April 2021

  • Sector

    Healthсare

  • Industry

    Life Sciences Tools & Services

  • Employees

    369

  • City

    Marlborough

  • Address

    100 Campus Drive, 6Th Floor

  • Cusip

    00974H104

Frequently Asked Questions

What sector does Akoya operate in?

Akoya operates in Healthсare sector

What is market cap of Akoya?

Market cap of Akoya is 0.117 USD as of 24 Jul 2024

What is market price of one AKYA stock?

Market price of one AKYA stock is 2.47 USD as of 24 Jul 2024

What is Akoya revenue?

According to the recent report Akoya revenue is 18.35

What is Akoya net income?

According to the recent report Akoya net icnome is -23.484

What is Akoya net income growh rate?

Net income growth rate of Akoya is 3